Main diagnosis (ICD9CM);Type of variable;Sex;Total ALL CAUSES (see exceptions in the methodology);patients discharged per 100,000 inhabitants;Both sexes;10,126 ALL CAUSES (see exceptions in the methodology);patients discharged per 100,000 inhabitants;Males;9,620 ALL CAUSES (see exceptions in the methodology);patients discharged per 100,000 inhabitants;Females;10,616 ALL CAUSES (see exceptions in the methodology);average stay by discharge;Both sexes;6.70 ALL CAUSES (see exceptions in the methodology);average stay by discharge;Males;7.28 ALL CAUSES (see exceptions in the methodology);average stay by discharge;Females;6.20 INFECTIOUS AND PARASITIC DISEASES 001-139 I;patients discharged per 100,000 inhabitants;Both sexes;188 INFECTIOUS AND PARASITIC DISEASES 001-139 I;patients discharged per 100,000 inhabitants;Males;215 INFECTIOUS AND PARASITIC DISEASES 001-139 I;patients discharged per 100,000 inhabitants;Females;163 INFECTIOUS AND PARASITIC DISEASES 001-139 I;average stay by discharge;Both sexes;8.82 INFECTIOUS AND PARASITIC DISEASES 001-139 I;average stay by discharge;Males;9.02 INFECTIOUS AND PARASITIC DISEASES 001-139 I;average stay by discharge;Females;8.58 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;patients discharged per 100,000 inhabitants;Both sexes;45 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;patients discharged per 100,000 inhabitants;Males;47 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;patients discharged per 100,000 inhabitants;Females;42 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;average stay by discharge;Both sexes;4.74 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;average stay by discharge;Males;4.61 INFECTIOUS INTESTINAL DISEASES (EXCEPT CHOLERA AND BOTULISM) 001-009 I.1;average stay by discharge;Females;4.88 Infections due to salmonella and other food-poisoning 003,005;patients discharged per 100,000 inhabitants;Both sexes;8 Infections due to salmonella and other food-poisoning 003,005;patients discharged per 100,000 inhabitants;Males;9 Infections due to salmonella and other food-poisoning 003,005;patients discharged per 100,000 inhabitants;Females;8 Infections due to salmonella and other food-poisoning 003,005;average stay by discharge;Both sexes;5.29 Infections due to salmonella and other food-poisoning 003,005;average stay by discharge;Males;5.39 Infections due to salmonella and other food-poisoning 003,005;average stay by discharge;Females;5.19 Imprecise intestinal infections 009;patients discharged per 100,000 inhabitants;Both sexes;15 Imprecise intestinal infections 009;patients discharged per 100,000 inhabitants;Males;15 Imprecise intestinal infections 009;patients discharged per 100,000 inhabitants;Females;15 Imprecise intestinal infections 009;average stay by discharge;Both sexes;4.01 Imprecise intestinal infections 009;average stay by discharge;Males;3.82 Imprecise intestinal infections 009;average stay by discharge;Females;4.20 Other intestinal infectious diseases Rest (001-009);patients discharged per 100,000 inhabitants;Both sexes;21 Other intestinal infectious diseases Rest (001-009);patients discharged per 100,000 inhabitants;Males;23 Other intestinal infectious diseases Rest (001-009);patients discharged per 100,000 inhabitants;Females;20 Other intestinal infectious diseases Rest (001-009);average stay by discharge;Both sexes;5.03 Other intestinal infectious diseases Rest (001-009);average stay by discharge;Males;4.81 Other intestinal infectious diseases Rest (001-009);average stay by discharge;Females;5.29 TUBERCULOSIS 010-018 I.2;patients discharged per 100,000 inhabitants;Both sexes;11 TUBERCULOSIS 010-018 I.2;patients discharged per 100,000 inhabitants;Males;14 TUBERCULOSIS 010-018 I.2;patients discharged per 100,000 inhabitants;Females;8 TUBERCULOSIS 010-018 I.2;average stay by discharge;Both sexes;14.73 TUBERCULOSIS 010-018 I.2;average stay by discharge;Males;15.51 TUBERCULOSIS 010-018 I.2;average stay by discharge;Females;13.33 Primary tuberculosis, lung infection and other tuberculosis of the respiratory system 010-012;patients discharged per 100,000 inhabitants;Both sexes;8 Primary tuberculosis, lung infection and other tuberculosis of the respiratory system 010-012;patients discharged per 100,000 inhabitants;Males;11 Primary tuberculosis, lung infection and other tuberculosis of the respiratory system 010-012;patients discharged per 100,000 inhabitants;Females;6 Primary tuberculosis, lung infection and other tuberculosis of the respiratory system 010-012;average stay by discharge;Both sexes;13.18 Primary tuberculosis, lung infection and other tuberculosis of the respiratory system 010-012;average stay by discharge;Males;14.12 Primary tuberculosis, lung infection and other tuberculosis of the respiratory system 010-012;average stay by discharge;Females;11.42 Other tuberculosis Rest (010-018);patients discharged per 100,000 inhabitants;Both sexes;2 Other tuberculosis Rest (010-018);patients discharged per 100,000 inhabitants;Males;3 Other tuberculosis Rest (010-018);patients discharged per 100,000 inhabitants;Females;2 Other tuberculosis Rest (010-018);average stay by discharge;Both sexes;20.04 Other tuberculosis Rest (010-018);average stay by discharge;Males;20.71 Other tuberculosis Rest (010-018);average stay by discharge;Females;19.03 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;patients discharged per 100,000 inhabitants;Both sexes;64 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;patients discharged per 100,000 inhabitants;Males;70 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;patients discharged per 100,000 inhabitants;Females;60 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;average stay by discharge;Both sexes;11.69 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;average stay by discharge;Males;11.97 BACTERIAL ZOONOTIC DISEASES AND OTHER BACTERIAL DISEASES (see exceptions in ICD Correspondence) 020-041 I.3;average stay by discharge;Females;11.38 Meningococcal Infection 036;patients discharged per 100,000 inhabitants;Both sexes;1 Meningococcal Infection 036;patients discharged per 100,000 inhabitants;Males;1 Meningococcal Infection 036;patients discharged per 100,000 inhabitants;Females;1 Meningococcal Infection 036;average stay by discharge;Both sexes;9.74 Meningococcal Infection 036;average stay by discharge;Males;9.98 Meningococcal Infection 036;average stay by discharge;Females;9.48 Septicemia 038;patients discharged per 100,000 inhabitants;Both sexes;55 Septicemia 038;patients discharged per 100,000 inhabitants;Males;59 Septicemia 038;patients discharged per 100,000 inhabitants;Females;51 Septicemia 038;average stay by discharge;Both sexes;12.16 Septicemia 038;average stay by discharge;Males;12.43 Septicemia 038;average stay by discharge;Females;11.87 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);patients discharged per 100,000 inhabitants;Both sexes;9 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);patients discharged per 100,000 inhabitants;Males;9 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);patients discharged per 100,000 inhabitants;Females;8 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);average stay by discharge;Both sexes;8.97 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);average stay by discharge;Males;9.36 Other bacterial zoonotic diseases and other bacterial diseases Rest (020-041);average stay by discharge;Females;8.52 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;patients discharged per 100,000 inhabitants;Both sexes;55 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;patients discharged per 100,000 inhabitants;Males;69 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;patients discharged per 100,000 inhabitants;Females;43 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;average stay by discharge;Both sexes;7.22 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;average stay by discharge;Males;7.36 VIRAL INFECTIONS (INCLUDING HIV) (EXCEPT POLIOMYELITIS, SMALLPOX, MEASLES, YELLOW FEVER AND RABIES) 042-079 I.4;average stay by discharge;Females;6.99 Illness caused by the human immunodeficiency virus (HIV) 042 *;patients discharged per 100,000 inhabitants;Both sexes;10 Illness caused by the human immunodeficiency virus (HIV) 042 *;patients discharged per 100,000 inhabitants;Males;14 Illness caused by the human immunodeficiency virus (HIV) 042 *;patients discharged per 100,000 inhabitants;Females;5 Illness caused by the human immunodeficiency virus (HIV) 042 *;average stay by discharge;Both sexes;14.03 Illness caused by the human immunodeficiency virus (HIV) 042 *;average stay by discharge;Males;14.26 Illness caused by the human immunodeficiency virus (HIV) 042 *;average stay by discharge;Females;13.42 Viral hepatitis 070;patients discharged per 100,000 inhabitants;Both sexes;10 Viral hepatitis 070;patients discharged per 100,000 inhabitants;Males;13 Viral hepatitis 070;patients discharged per 100,000 inhabitants;Females;7 Viral hepatitis 070;average stay by discharge;Both sexes;6.09 Viral hepatitis 070;average stay by discharge;Males;5.68 Viral hepatitis 070;average stay by discharge;Females;6.90 Other viral diseases Rest (042-079);patients discharged per 100,000 inhabitants;Both sexes;36 Other viral diseases Rest (042-079);patients discharged per 100,000 inhabitants;Males;41 Other viral diseases Rest (042-079);patients discharged per 100,000 inhabitants;Females;31 Other viral diseases Rest (042-079);average stay by discharge;Both sexes;5.63 Other viral diseases Rest (042-079);average stay by discharge;Males;5.45 Other viral diseases Rest (042-079);average stay by discharge;Females;5.86 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;patients discharged per 100,000 inhabitants;Both sexes;13 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;patients discharged per 100,000 inhabitants;Males;16 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;patients discharged per 100,000 inhabitants;Females;10 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;average stay by discharge;Both sexes;10.57 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;average stay by discharge;Males;10.48 OTHER INFECTIOUS DISEASES (see exceptions in ICD Correspondence) 080-139 I.5;average stay by discharge;Females;10.72 TUMOURS 140-239 II;patients discharged per 100,000 inhabitants;Both sexes;961 TUMOURS 140-239 II;patients discharged per 100,000 inhabitants;Males;1,030 TUMOURS 140-239 II;patients discharged per 100,000 inhabitants;Females;895 TUMOURS 140-239 II;average stay by discharge;Both sexes;8.41 TUMOURS 140-239 II;average stay by discharge;Males;9.15 TUMOURS 140-239 II;average stay by discharge;Females;7.59 MALIGNANT TUMOURS 140-209 II.1;patients discharged per 100,000 inhabitants;Both sexes;752 MALIGNANT TUMOURS 140-209 II.1;patients discharged per 100,000 inhabitants;Males;890 MALIGNANT TUMOURS 140-209 II.1;patients discharged per 100,000 inhabitants;Females;618 MALIGNANT TUMOURS 140-209 II.1;average stay by discharge;Both sexes;9.41 MALIGNANT TUMOURS 140-209 II.1;average stay by discharge;Males;9.71 MALIGNANT TUMOURS 140-209 II.1;average stay by discharge;Females;8.99 Malignant neoplasm of the oesophagus 150;patients discharged per 100,000 inhabitants;Both sexes;8 Malignant neoplasm of the oesophagus 150;patients discharged per 100,000 inhabitants;Males;14 Malignant neoplasm of the oesophagus 150;patients discharged per 100,000 inhabitants;Females;2 Malignant neoplasm of the oesophagus 150;average stay by discharge;Both sexes;13.40 Malignant neoplasm of the oesophagus 150;average stay by discharge;Males;13.17 Malignant neoplasm of the oesophagus 150;average stay by discharge;Females;14.83 Malignant neoplasm of the stomach 151;patients discharged per 100,000 inhabitants;Both sexes;24 Malignant neoplasm of the stomach 151;patients discharged per 100,000 inhabitants;Males;31 Malignant neoplasm of the stomach 151;patients discharged per 100,000 inhabitants;Females;18 Malignant neoplasm of the stomach 151;average stay by discharge;Both sexes;14.08 Malignant neoplasm of the stomach 151;average stay by discharge;Males;13.91 Malignant neoplasm of the stomach 151;average stay by discharge;Females;14.38 Malignant neoplasm of the colon and rectum 153-154;patients discharged per 100,000 inhabitants;Both sexes;98 Malignant neoplasm of the colon and rectum 153-154;patients discharged per 100,000 inhabitants;Males;121 Malignant neoplasm of the colon and rectum 153-154;patients discharged per 100,000 inhabitants;Females;76 Malignant neoplasm of the colon and rectum 153-154;average stay by discharge;Both sexes;13.12 Malignant neoplasm of the colon and rectum 153-154;average stay by discharge;Males;13.33 Malignant neoplasm of the colon and rectum 153-154;average stay by discharge;Females;12.81 Malignant tumour of the larynx 161;patients discharged per 100,000 inhabitants;Both sexes;12 Malignant tumour of the larynx 161;patients discharged per 100,000 inhabitants;Males;23 Malignant tumour of the larynx 161;patients discharged per 100,000 inhabitants;Females;2 Malignant tumour of the larynx 161;average stay by discharge;Both sexes;11.71 Malignant tumour of the larynx 161;average stay by discharge;Males;11.71 Malignant tumour of the larynx 161;average stay by discharge;Females;11.65 Malignant neoplasm of trachea, bronchus and lung 162;patients discharged per 100,000 inhabitants;Both sexes;71 Malignant neoplasm of trachea, bronchus and lung 162;patients discharged per 100,000 inhabitants;Males;117 Malignant neoplasm of trachea, bronchus and lung 162;patients discharged per 100,000 inhabitants;Females;26 Malignant neoplasm of trachea, bronchus and lung 162;average stay by discharge;Both sexes;9.96 Malignant neoplasm of trachea, bronchus and lung 162;average stay by discharge;Males;9.93 Malignant neoplasm of trachea, bronchus and lung 162;average stay by discharge;Females;10.11 Malignant tumour of the skin 172-173 *;patients discharged per 100,000 inhabitants;Both sexes;20 Malignant tumour of the skin 172-173 *;patients discharged per 100,000 inhabitants;Males;23 Malignant tumour of the skin 172-173 *;patients discharged per 100,000 inhabitants;Females;17 Malignant tumour of the skin 172-173 *;average stay by discharge;Both sexes;4.37 Malignant tumour of the skin 172-173 *;average stay by discharge;Males;4.45 Malignant tumour of the skin 172-173 *;average stay by discharge;Females;4.27 Malignant neoplasm of the breast 174-175;patients discharged per 100,000 inhabitants;Both sexes;72 Malignant neoplasm of the breast 174-175;patients discharged per 100,000 inhabitants;Males;1 Malignant neoplasm of the breast 174-175;patients discharged per 100,000 inhabitants;Females;140 Malignant neoplasm of the breast 174-175;average stay by discharge;Both sexes;4.47 Malignant neoplasm of the breast 174-175;average stay by discharge;Males;5.20 Malignant neoplasm of the breast 174-175;average stay by discharge;Females;4.46 Malignant tumour of the uterus 179-180.182 *;patients discharged per 100,000 inhabitants;Both sexes;21 Malignant tumour of the uterus 179-180.182 *;patients discharged per 100,000 inhabitants;Males;.. Malignant tumour of the uterus 179-180.182 *;patients discharged per 100,000 inhabitants;Females;41 Malignant tumour of the uterus 179-180.182 *;average stay by discharge;Both sexes;6.79 Malignant tumour of the uterus 179-180.182 *;average stay by discharge;Males;.. Malignant tumour of the uterus 179-180.182 *;average stay by discharge;Females;6.79 Malignant tumour of the prostate 185;patients discharged per 100,000 inhabitants;Both sexes;41 Malignant tumour of the prostate 185;patients discharged per 100,000 inhabitants;Males;83 Malignant tumour of the prostate 185;patients discharged per 100,000 inhabitants;Females;.. Malignant tumour of the prostate 185;average stay by discharge;Both sexes;5.89 Malignant tumour of the prostate 185;average stay by discharge;Males;5.89 Malignant tumour of the prostate 185;average stay by discharge;Females;.. Malignant tumour of the bladder 188 *;patients discharged per 100,000 inhabitants;Both sexes;85 Malignant tumour of the bladder 188 *;patients discharged per 100,000 inhabitants;Males;146 Malignant tumour of the bladder 188 *;patients discharged per 100,000 inhabitants;Females;26 Malignant tumour of the bladder 188 *;average stay by discharge;Both sexes;5.05 Malignant tumour of the bladder 188 *;average stay by discharge;Males;5.10 Malignant tumour of the bladder 188 *;average stay by discharge;Females;4.81 Lymphomas 200-202;patients discharged per 100,000 inhabitants;Both sexes;27 Lymphomas 200-202;patients discharged per 100,000 inhabitants;Males;30 Lymphomas 200-202;patients discharged per 100,000 inhabitants;Females;23 Lymphomas 200-202;average stay by discharge;Both sexes;12.71 Lymphomas 200-202;average stay by discharge;Males;12.63 Lymphomas 200-202;average stay by discharge;Females;12.82 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;patients discharged per 100,000 inhabitants;Both sexes;29 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;patients discharged per 100,000 inhabitants;Males;33 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;patients discharged per 100,000 inhabitants;Females;25 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;average stay by discharge;Both sexes;16.83 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;average stay by discharge;Males;16.75 Malignant tumour of the hematopoietic and neuroendocrine tissues 204-208;average stay by discharge;Females;16.93 Other malignant neoplasms Rest (140-209);patients discharged per 100,000 inhabitants;Both sexes;245 Other malignant neoplasms Rest (140-209);patients discharged per 100,000 inhabitants;Males;267 Other malignant neoplasms Rest (140-209);patients discharged per 100,000 inhabitants;Females;223 Other malignant neoplasms Rest (140-209);average stay by discharge;Both sexes;10.00 Other malignant neoplasms Rest (140-209);average stay by discharge;Males;10.11 Other malignant neoplasms Rest (140-209);average stay by discharge;Females;9.86 BENIGN TUMOURS 210-229 II.2;patients discharged per 100,000 inhabitants;Both sexes;145 BENIGN TUMOURS 210-229 II.2;patients discharged per 100,000 inhabitants;Males;75 BENIGN TUMOURS 210-229 II.2;patients discharged per 100,000 inhabitants;Females;213 BENIGN TUMOURS 210-229 II.2;average stay by discharge;Both sexes;4.46 BENIGN TUMOURS 210-229 II.2;average stay by discharge;Males;5.04 BENIGN TUMOURS 210-229 II.2;average stay by discharge;Females;4.26 Uterine leiomyoma 218 *;patients discharged per 100,000 inhabitants;Both sexes;50 Uterine leiomyoma 218 *;patients discharged per 100,000 inhabitants;Males;.. Uterine leiomyoma 218 *;patients discharged per 100,000 inhabitants;Females;99 Uterine leiomyoma 218 *;average stay by discharge;Both sexes;4.01 Uterine leiomyoma 218 *;average stay by discharge;Males;.. Uterine leiomyoma 218 *;average stay by discharge;Females;4.01 Other benign tumours of the uterus 219 *;patients discharged per 100,000 inhabitants;Both sexes;1 Other benign tumours of the uterus 219 *;patients discharged per 100,000 inhabitants;Males;.. Other benign tumours of the uterus 219 *;patients discharged per 100,000 inhabitants;Females;2 Other benign tumours of the uterus 219 *;average stay by discharge;Both sexes;3.83 Other benign tumours of the uterus 219 *;average stay by discharge;Males;.. Other benign tumours of the uterus 219 *;average stay by discharge;Females;3.83 Other benign tumours Rest (210-229);patients discharged per 100,000 inhabitants;Both sexes;94 Other benign tumours Rest (210-229);patients discharged per 100,000 inhabitants;Males;75 Other benign tumours Rest (210-229);patients discharged per 100,000 inhabitants;Females;112 Other benign tumours Rest (210-229);average stay by discharge;Both sexes;4.71 Other benign tumours Rest (210-229);average stay by discharge;Males;5.04 Other benign tumours Rest (210-229);average stay by discharge;Females;4.49 PREINVASIVE CARCINOMA 230-234 II.3;patients discharged per 100,000 inhabitants;Both sexes;17 PREINVASIVE CARCINOMA 230-234 II.3;patients discharged per 100,000 inhabitants;Males;11 PREINVASIVE CARCINOMA 230-234 II.3;patients discharged per 100,000 inhabitants;Females;22 PREINVASIVE CARCINOMA 230-234 II.3;average stay by discharge;Both sexes;4.70 PREINVASIVE CARCINOMA 230-234 II.3;average stay by discharge;Males;6.66 PREINVASIVE CARCINOMA 230-234 II.3;average stay by discharge;Females;3.78 NON SPECIFIED TUMOURS 235-239 II.4;patients discharged per 100,000 inhabitants;Both sexes;48 NON SPECIFIED TUMOURS 235-239 II.4;patients discharged per 100,000 inhabitants;Males;53 NON SPECIFIED TUMOURS 235-239 II.4;patients discharged per 100,000 inhabitants;Females;42 NON SPECIFIED TUMOURS 235-239 II.4;average stay by discharge;Both sexes;6.05 NON SPECIFIED TUMOURS 235-239 II.4;average stay by discharge;Males;6.15 NON SPECIFIED TUMOURS 235-239 II.4;average stay by discharge;Females;5.94 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;patients discharged per 100,000 inhabitants;Both sexes;184 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;patients discharged per 100,000 inhabitants;Males;153 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;patients discharged per 100,000 inhabitants;Females;214 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;average stay by discharge;Both sexes;6.54 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;average stay by discharge;Males;7.54 ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASE AND IMMUNITY DISORDERS 240-279 III;average stay by discharge;Females;5.84 DISORDERS OF THE THYROID GLAND 240-246 III.1;patients discharged per 100,000 inhabitants;Both sexes;40 DISORDERS OF THE THYROID GLAND 240-246 III.1;patients discharged per 100,000 inhabitants;Males;15 DISORDERS OF THE THYROID GLAND 240-246 III.1;patients discharged per 100,000 inhabitants;Females;64 DISORDERS OF THE THYROID GLAND 240-246 III.1;average stay by discharge;Both sexes;3.26 DISORDERS OF THE THYROID GLAND 240-246 III.1;average stay by discharge;Males;3.62 DISORDERS OF THE THYROID GLAND 240-246 III.1;average stay by discharge;Females;3.17 Diseases of other endocrine glands 249-259 III.2;patients discharged per 100,000 inhabitants;Both sexes;77 Diseases of other endocrine glands 249-259 III.2;patients discharged per 100,000 inhabitants;Males;83 Diseases of other endocrine glands 249-259 III.2;patients discharged per 100,000 inhabitants;Females;72 Diseases of other endocrine glands 249-259 III.2;average stay by discharge;Both sexes;7.97 Diseases of other endocrine glands 249-259 III.2;average stay by discharge;Males;8.46 Diseases of other endocrine glands 249-259 III.2;average stay by discharge;Females;7.42 Diabetes mellitus 249-250;patients discharged per 100,000 inhabitants;Both sexes;65 Diabetes mellitus 249-250;patients discharged per 100,000 inhabitants;Males;74 Diabetes mellitus 249-250;patients discharged per 100,000 inhabitants;Females;56 Diabetes mellitus 249-250;average stay by discharge;Both sexes;8.39 Diabetes mellitus 249-250;average stay by discharge;Males;8.73 Diabetes mellitus 249-250;average stay by discharge;Females;7.97 Other diseases of the endocrine glands Rest (249-259);patients discharged per 100,000 inhabitants;Both sexes;12 Other diseases of the endocrine glands Rest (249-259);patients discharged per 100,000 inhabitants;Males;9 Other diseases of the endocrine glands Rest (249-259);patients discharged per 100,000 inhabitants;Females;16 Other diseases of the endocrine glands Rest (249-259);average stay by discharge;Both sexes;5.72 Other diseases of the endocrine glands Rest (249-259);average stay by discharge;Males;6.12 Other diseases of the endocrine glands Rest (249-259);average stay by discharge;Females;5.52 NUTRITIONAL DEFICIENCIES 260-269 III.3;patients discharged per 100,000 inhabitants;Both sexes;3 NUTRITIONAL DEFICIENCIES 260-269 III.3;patients discharged per 100,000 inhabitants;Males;3 NUTRITIONAL DEFICIENCIES 260-269 III.3;patients discharged per 100,000 inhabitants;Females;3 NUTRITIONAL DEFICIENCIES 260-269 III.3;average stay by discharge;Both sexes;13.73 NUTRITIONAL DEFICIENCIES 260-269 III.3;average stay by discharge;Males;13.41 NUTRITIONAL DEFICIENCIES 260-269 III.3;average stay by discharge;Females;14.11 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;patients discharged per 100,000 inhabitants;Both sexes;64 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;patients discharged per 100,000 inhabitants;Males;52 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;patients discharged per 100,000 inhabitants;Females;75 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;average stay by discharge;Both sexes;6.49 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;average stay by discharge;Males;6.82 OTHER METABOLIC DISEASES AND IMMUNITY DISORDERS 270-279 III.4;average stay by discharge;Females;6.28 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;patients discharged per 100,000 inhabitants;Both sexes;96 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;patients discharged per 100,000 inhabitants;Males;95 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;patients discharged per 100,000 inhabitants;Females;96 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;average stay by discharge;Both sexes;6.82 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;average stay by discharge;Males;6.98 DISEASES OF THE BLOOD AND BLOOD FORMING ORGANS 280-289 IV;average stay by discharge;Females;6.67 Anaemia 280-285;patients discharged per 100,000 inhabitants;Both sexes;56 Anaemia 280-285;patients discharged per 100,000 inhabitants;Males;53 Anaemia 280-285;patients discharged per 100,000 inhabitants;Females;58 Anaemia 280-285;average stay by discharge;Both sexes;7.11 Anaemia 280-285;average stay by discharge;Males;7.17 Anaemia 280-285;average stay by discharge;Females;7.05 Other diseases of the blood and blood forming organs Rest (280-289);patients discharged per 100,000 inhabitants;Both sexes;40 Other diseases of the blood and blood forming organs Rest (280-289);patients discharged per 100,000 inhabitants;Males;42 Other diseases of the blood and blood forming organs Rest (280-289);patients discharged per 100,000 inhabitants;Females;38 Other diseases of the blood and blood forming organs Rest (280-289);average stay by discharge;Both sexes;6.43 Other diseases of the blood and blood forming organs Rest (280-289);average stay by discharge;Males;6.74 Other diseases of the blood and blood forming organs Rest (280-289);average stay by discharge;Females;6.09 MENTAL DISORDERS 290-319 V;patients discharged per 100,000 inhabitants;Both sexes;249 MENTAL DISORDERS 290-319 V;patients discharged per 100,000 inhabitants;Males;268 MENTAL DISORDERS 290-319 V;patients discharged per 100,000 inhabitants;Females;231 MENTAL DISORDERS 290-319 V;average stay by discharge;Both sexes;25.88 MENTAL DISORDERS 290-319 V;average stay by discharge;Males;26.70 MENTAL DISORDERS 290-319 V;average stay by discharge;Females;24.96 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;patients discharged per 100,000 inhabitants;Both sexes;175 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;patients discharged per 100,000 inhabitants;Males;204 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;patients discharged per 100,000 inhabitants;Females;146 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;average stay by discharge;Both sexes;24.65 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;average stay by discharge;Males;23.90 PSYCHOSIS AND MENTAL DISORDERS INDUCED BY THE USE OF DRUGS OR ALCOHOL 290-299,303-305 V.1 *;average stay by discharge;Females;25.65 Senile and presenile organic psychotic conditions (see methodology) 290;patients discharged per 100,000 inhabitants;Both sexes;10 Senile and presenile organic psychotic conditions (see methodology) 290;patients discharged per 100,000 inhabitants;Males;8 Senile and presenile organic psychotic conditions (see methodology) 290;patients discharged per 100,000 inhabitants;Females;11 Senile and presenile organic psychotic conditions (see methodology) 290;average stay by discharge;Both sexes;62.20 Senile and presenile organic psychotic conditions (see methodology) 290;average stay by discharge;Males;56.93 Senile and presenile organic psychotic conditions (see methodology) 290;average stay by discharge;Females;66.14 Schizophrenic disorders (see methodology) 295;patients discharged per 100,000 inhabitants;Both sexes;51 Schizophrenic disorders (see methodology) 295;patients discharged per 100,000 inhabitants;Males;67 Schizophrenic disorders (see methodology) 295;patients discharged per 100,000 inhabitants;Females;35 Schizophrenic disorders (see methodology) 295;average stay by discharge;Both sexes;35.86 Schizophrenic disorders (see methodology) 295;average stay by discharge;Males;36.07 Schizophrenic disorders (see methodology) 295;average stay by discharge;Females;35.45 Mental and behavioural disorders induced by the use of alcohol 291.303;patients discharged per 100,000 inhabitants;Both sexes;19 Mental and behavioural disorders induced by the use of alcohol 291.303;patients discharged per 100,000 inhabitants;Males;29 Mental and behavioural disorders induced by the use of alcohol 291.303;patients discharged per 100,000 inhabitants;Females;9 Mental and behavioural disorders induced by the use of alcohol 291.303;average stay by discharge;Both sexes;12.37 Mental and behavioural disorders induced by the use of alcohol 291.303;average stay by discharge;Males;12.17 Mental and behavioural disorders induced by the use of alcohol 291.303;average stay by discharge;Females;12.99 Mental and behavioural disorders induced by the use of drugs 292304-305 *;patients discharged per 100,000 inhabitants;Both sexes;17 Mental and behavioural disorders induced by the use of drugs 292304-305 *;patients discharged per 100,000 inhabitants;Males;26 Mental and behavioural disorders induced by the use of drugs 292304-305 *;patients discharged per 100,000 inhabitants;Females;9 Mental and behavioural disorders induced by the use of drugs 292304-305 *;average stay by discharge;Both sexes;10.49 Mental and behavioural disorders induced by the use of drugs 292304-305 *;average stay by discharge;Males;10.49 Mental and behavioural disorders induced by the use of drugs 292304-305 *;average stay by discharge;Females;10.50 Other psychosis 293-294.296-299 *;patients discharged per 100,000 inhabitants;Both sexes;78 Other psychosis 293-294.296-299 *;patients discharged per 100,000 inhabitants;Males;73 Other psychosis 293-294.296-299 *;patients discharged per 100,000 inhabitants;Females;83 Other psychosis 293-294.296-299 *;average stay by discharge;Both sexes;18.82 Other psychosis 293-294.296-299 *;average stay by discharge;Males;18.35 Other psychosis 293-294.296-299 *;average stay by discharge;Females;19.23 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;patients discharged per 100,000 inhabitants;Both sexes;74 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;patients discharged per 100,000 inhabitants;Males;64 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;patients discharged per 100,000 inhabitants;Females;85 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;average stay by discharge;Both sexes;28.77 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;average stay by discharge;Males;35.65 NEUROTIC AND PERSONALITY DISORDERS AND OTHER NON PSYCHOTIC DISORDERS (EXCEPT DRUGS OR ALCOHOL). MENTAL RETARDATION 300-302,306-319 V.2 *;average stay by discharge;Females;23.77 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;patients discharged per 100,000 inhabitants;Both sexes;72 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;patients discharged per 100,000 inhabitants;Males;60 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;patients discharged per 100,000 inhabitants;Females;83 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;average stay by discharge;Both sexes;12.99 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;average stay by discharge;Males;11.57 Neurotic and personality disorders and other non psychotic mental disorders 300-302.306-316 *;average stay by discharge;Females;13.98 Other mental disorders (see methodology ) Rest (300-302,306-319) *;patients discharged per 100,000 inhabitants;Both sexes;3 Other mental disorders (see methodology ) Rest (300-302,306-319) *;patients discharged per 100,000 inhabitants;Males;4 Other mental disorders (see methodology ) Rest (300-302,306-319) *;patients discharged per 100,000 inhabitants;Females;2 Other mental disorders (see methodology ) Rest (300-302,306-319) *;average stay by discharge;Both sexes;436.35 Other mental disorders (see methodology ) Rest (300-302,306-319) *;average stay by discharge;Males;423.99 Other mental disorders (see methodology ) Rest (300-302,306-319) *;average stay by discharge;Females;460.28 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;patients discharged per 100,000 inhabitants;Both sexes;312 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;patients discharged per 100,000 inhabitants;Males;321 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;patients discharged per 100,000 inhabitants;Females;304 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;average stay by discharge;Both sexes;6.17 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;average stay by discharge;Males;6.09 DISEASES OF THE NERVOUS SYSTEM AND SENSORY ORGANS 320-389 VI;average stay by discharge;Females;6.26 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;patients discharged per 100,000 inhabitants;Both sexes;182 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;patients discharged per 100,000 inhabitants;Males;188 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;patients discharged per 100,000 inhabitants;Females;175 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;average stay by discharge;Both sexes;8.57 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;average stay by discharge;Males;8.35 INFLAMMATORY DISEASES OF THE CENTRAL NERVOUS SYSTEM 320-359 VI.1;average stay by discharge;Females;8.80 Parkinson Disease 332;patients discharged per 100,000 inhabitants;Both sexes;5 Parkinson Disease 332;patients discharged per 100,000 inhabitants;Males;6 Parkinson Disease 332;patients discharged per 100,000 inhabitants;Females;5 Parkinson Disease 332;average stay by discharge;Both sexes;12.71 Parkinson Disease 332;average stay by discharge;Males;12.77 Parkinson Disease 332;average stay by discharge;Females;12.63 Multiple sclerosis 340;patients discharged per 100,000 inhabitants;Both sexes;6 Multiple sclerosis 340;patients discharged per 100,000 inhabitants;Males;3 Multiple sclerosis 340;patients discharged per 100,000 inhabitants;Females;8 Multiple sclerosis 340;average stay by discharge;Both sexes;7.25 Multiple sclerosis 340;average stay by discharge;Males;6.96 Multiple sclerosis 340;average stay by discharge;Females;7.38 Epilepsy 345;patients discharged per 100,000 inhabitants;Both sexes;36 Epilepsy 345;patients discharged per 100,000 inhabitants;Males;39 Epilepsy 345;patients discharged per 100,000 inhabitants;Females;33 Epilepsy 345;average stay by discharge;Both sexes;5.96 Epilepsy 345;average stay by discharge;Males;5.90 Epilepsy 345;average stay by discharge;Females;6.03 Other diseases of the central nervous system Rest (320-359);patients discharged per 100,000 inhabitants;Both sexes;135 Other diseases of the central nervous system Rest (320-359);patients discharged per 100,000 inhabitants;Males;140 Other diseases of the central nervous system Rest (320-359);patients discharged per 100,000 inhabitants;Females;131 Other diseases of the central nervous system Rest (320-359);average stay by discharge;Both sexes;9.16 Other diseases of the central nervous system Rest (320-359);average stay by discharge;Males;8.89 Other diseases of the central nervous system Rest (320-359);average stay by discharge;Females;9.44 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;patients discharged per 100,000 inhabitants;Both sexes;77 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;patients discharged per 100,000 inhabitants;Males;80 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;patients discharged per 100,000 inhabitants;Females;74 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;average stay by discharge;Both sexes;2.91 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;average stay by discharge;Males;2.98 DISEASES OF THE EYE AND ADNEXA 360-379 VI.2;average stay by discharge;Females;2.83 Cataract 366 *;patients discharged per 100,000 inhabitants;Both sexes;18 Cataract 366 *;patients discharged per 100,000 inhabitants;Males;17 Cataract 366 *;patients discharged per 100,000 inhabitants;Females;18 Cataract 366 *;average stay by discharge;Both sexes;1.61 Cataract 366 *;average stay by discharge;Males;1.64 Cataract 366 *;average stay by discharge;Females;1.59 Other disorders of the eye & adnexa Rest (360-379) *;patients discharged per 100,000 inhabitants;Both sexes;59 Other disorders of the eye & adnexa Rest (360-379) *;patients discharged per 100,000 inhabitants;Males;62 Other disorders of the eye & adnexa Rest (360-379) *;patients discharged per 100,000 inhabitants;Females;56 Other disorders of the eye & adnexa Rest (360-379) *;average stay by discharge;Both sexes;3.30 Other disorders of the eye & adnexa Rest (360-379) *;average stay by discharge;Males;3.36 Other disorders of the eye & adnexa Rest (360-379) *;average stay by discharge;Females;3.24 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;patients discharged per 100,000 inhabitants;Both sexes;54 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;patients discharged per 100,000 inhabitants;Males;53 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;patients discharged per 100,000 inhabitants;Females;54 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;average stay by discharge;Both sexes;2.71 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;average stay by discharge;Males;2.71 DISEASES OF THE EAR AND MASTOID PROCESS 380-389 VI.3;average stay by discharge;Females;2.71 Otitis media 381-382 *;patients discharged per 100,000 inhabitants;Both sexes;14 Otitis media 381-382 *;patients discharged per 100,000 inhabitants;Males;16 Otitis media 381-382 *;patients discharged per 100,000 inhabitants;Females;13 Otitis media 381-382 *;average stay by discharge;Both sexes;2.21 Otitis media 381-382 *;average stay by discharge;Males;2.23 Otitis media 381-382 *;average stay by discharge;Females;2.18 Other diseases of the ear Rest (380-389) *;patients discharged per 100,000 inhabitants;Both sexes;39 Other diseases of the ear Rest (380-389) *;patients discharged per 100,000 inhabitants;Males;38 Other diseases of the ear Rest (380-389) *;patients discharged per 100,000 inhabitants;Females;41 Other diseases of the ear Rest (380-389) *;average stay by discharge;Both sexes;2.89 Other diseases of the ear Rest (380-389) *;average stay by discharge;Males;2.91 Other diseases of the ear Rest (380-389) *;average stay by discharge;Females;2.88 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;patients discharged per 100,000 inhabitants;Both sexes;1,315 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;patients discharged per 100,000 inhabitants;Males;1,482 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;patients discharged per 100,000 inhabitants;Females;1,153 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;average stay by discharge;Both sexes;7.78 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;average stay by discharge;Males;7.71 DISEASES OF THE CIRCULATORY SYSTEM 390-459 VII;average stay by discharge;Females;7.86 ACCUTE RHEUMATIC FEVER 390-392 VII.1;patients discharged per 100,000 inhabitants;Both sexes;0 ACCUTE RHEUMATIC FEVER 390-392 VII.1;patients discharged per 100,000 inhabitants;Males;0 ACCUTE RHEUMATIC FEVER 390-392 VII.1;patients discharged per 100,000 inhabitants;Females;0 ACCUTE RHEUMATIC FEVER 390-392 VII.1;average stay by discharge;Both sexes;12.15 ACCUTE RHEUMATIC FEVER 390-392 VII.1;average stay by discharge;Males;14.03 ACCUTE RHEUMATIC FEVER 390-392 VII.1;average stay by discharge;Females;9.97 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;patients discharged per 100,000 inhabitants;Both sexes;16 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;patients discharged per 100,000 inhabitants;Males;10 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;patients discharged per 100,000 inhabitants;Females;22 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;average stay by discharge;Both sexes;10.84 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;average stay by discharge;Males;11.40 CHRONIC RHEUMATIC HEART DISEASE 393-398 VII.2;average stay by discharge;Females;10.60 HYPERTENSIVE DISEASES 401-405 VII.3;patients discharged per 100,000 inhabitants;Both sexes;63 HYPERTENSIVE DISEASES 401-405 VII.3;patients discharged per 100,000 inhabitants;Males;54 HYPERTENSIVE DISEASES 401-405 VII.3;patients discharged per 100,000 inhabitants;Females;72 HYPERTENSIVE DISEASES 401-405 VII.3;average stay by discharge;Both sexes;8.24 HYPERTENSIVE DISEASES 401-405 VII.3;average stay by discharge;Males;8.13 HYPERTENSIVE DISEASES 401-405 VII.3;average stay by discharge;Females;8.32 ISCHAEMIC CARDIOPATHY 410-414 VII.4;patients discharged per 100,000 inhabitants;Both sexes;268 ISCHAEMIC CARDIOPATHY 410-414 VII.4;patients discharged per 100,000 inhabitants;Males;386 ISCHAEMIC CARDIOPATHY 410-414 VII.4;patients discharged per 100,000 inhabitants;Females;154 ISCHAEMIC CARDIOPATHY 410-414 VII.4;average stay by discharge;Both sexes;6.72 ISCHAEMIC CARDIOPATHY 410-414 VII.4;average stay by discharge;Males;6.59 ISCHAEMIC CARDIOPATHY 410-414 VII.4;average stay by discharge;Females;7.05 Acute myocardial infarction 410;patients discharged per 100,000 inhabitants;Both sexes;114 Acute myocardial infarction 410;patients discharged per 100,000 inhabitants;Males;163 Acute myocardial infarction 410;patients discharged per 100,000 inhabitants;Females;67 Acute myocardial infarction 410;average stay by discharge;Both sexes;7.63 Acute myocardial infarction 410;average stay by discharge;Males;7.45 Acute myocardial infarction 410;average stay by discharge;Females;8.04 Other ischaemic heart diseases 411-412.414 *;patients discharged per 100,000 inhabitants;Both sexes;134 Other ischaemic heart diseases 411-412.414 *;patients discharged per 100,000 inhabitants;Males;199 Other ischaemic heart diseases 411-412.414 *;patients discharged per 100,000 inhabitants;Females;72 Other ischaemic heart diseases 411-412.414 *;average stay by discharge;Both sexes;6.20 Other ischaemic heart diseases 411-412.414 *;average stay by discharge;Males;6.07 Other ischaemic heart diseases 411-412.414 *;average stay by discharge;Females;6.55 Angina pectoris 413 *;patients discharged per 100,000 inhabitants;Both sexes;20 Angina pectoris 413 *;patients discharged per 100,000 inhabitants;Males;24 Angina pectoris 413 *;patients discharged per 100,000 inhabitants;Females;15 Angina pectoris 413 *;average stay by discharge;Both sexes;5.01 Angina pectoris 413 *;average stay by discharge;Males;4.98 Angina pectoris 413 *;average stay by discharge;Females;5.06 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;patients discharged per 100,000 inhabitants;Both sexes;39 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;patients discharged per 100,000 inhabitants;Males;36 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;patients discharged per 100,000 inhabitants;Females;42 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;average stay by discharge;Both sexes;9.65 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;average stay by discharge;Males;9.44 DISEASES OF PULMONARY CIRCULATION 415-417 VII.5;average stay by discharge;Females;9.82 OTHER FORMS OF HEART DISEASES 420-429 VII.6;patients discharged per 100,000 inhabitants;Both sexes;461 OTHER FORMS OF HEART DISEASES 420-429 VII.6;patients discharged per 100,000 inhabitants;Males;476 OTHER FORMS OF HEART DISEASES 420-429 VII.6;patients discharged per 100,000 inhabitants;Females;447 OTHER FORMS OF HEART DISEASES 420-429 VII.6;average stay by discharge;Both sexes;7.67 OTHER FORMS OF HEART DISEASES 420-429 VII.6;average stay by discharge;Males;7.58 OTHER FORMS OF HEART DISEASES 420-429 VII.6;average stay by discharge;Females;7.77 Conduction disorders and cardiac dysrhythmias 426-427 *;patients discharged per 100,000 inhabitants;Both sexes;157 Conduction disorders and cardiac dysrhythmias 426-427 *;patients discharged per 100,000 inhabitants;Males;171 Conduction disorders and cardiac dysrhythmias 426-427 *;patients discharged per 100,000 inhabitants;Females;143 Conduction disorders and cardiac dysrhythmias 426-427 *;average stay by discharge;Both sexes;5.24 Conduction disorders and cardiac dysrhythmias 426-427 *;average stay by discharge;Males;5.10 Conduction disorders and cardiac dysrhythmias 426-427 *;average stay by discharge;Females;5.41 Heart failure 428 *;patients discharged per 100,000 inhabitants;Both sexes;238 Heart failure 428 *;patients discharged per 100,000 inhabitants;Males;223 Heart failure 428 *;patients discharged per 100,000 inhabitants;Females;253 Heart failure 428 *;average stay by discharge;Both sexes;8.75 Heart failure 428 *;average stay by discharge;Males;8.84 Heart failure 428 *;average stay by discharge;Females;8.67 Other heart diseases Rest (420-429) *;patients discharged per 100,000 inhabitants;Both sexes;66 Other heart diseases Rest (420-429) *;patients discharged per 100,000 inhabitants;Males;81 Other heart diseases Rest (420-429) *;patients discharged per 100,000 inhabitants;Females;51 Other heart diseases Rest (420-429) *;average stay by discharge;Both sexes;9.58 Other heart diseases Rest (420-429) *;average stay by discharge;Males;9.37 Other heart diseases Rest (420-429) *;average stay by discharge;Females;9.91 CEREBROVASCULAR DISEASES 430-438 VII.7;patients discharged per 100,000 inhabitants;Both sexes;252 CEREBROVASCULAR DISEASES 430-438 VII.7;patients discharged per 100,000 inhabitants;Males;272 CEREBROVASCULAR DISEASES 430-438 VII.7;patients discharged per 100,000 inhabitants;Females;232 CEREBROVASCULAR DISEASES 430-438 VII.7;average stay by discharge;Both sexes;10.02 CEREBROVASCULAR DISEASES 430-438 VII.7;average stay by discharge;Males;9.87 CEREBROVASCULAR DISEASES 430-438 VII.7;average stay by discharge;Females;10.20 Transient cerebral ischemia 435 *;patients discharged per 100,000 inhabitants;Both sexes;32 Transient cerebral ischemia 435 *;patients discharged per 100,000 inhabitants;Males;33 Transient cerebral ischemia 435 *;patients discharged per 100,000 inhabitants;Females;32 Transient cerebral ischemia 435 *;average stay by discharge;Both sexes;5.39 Transient cerebral ischemia 435 *;average stay by discharge;Males;5.39 Transient cerebral ischemia 435 *;average stay by discharge;Females;5.39 Other cerebrovascular diseases Rest (430-438) *;patients discharged per 100,000 inhabitants;Both sexes;219 Other cerebrovascular diseases Rest (430-438) *;patients discharged per 100,000 inhabitants;Males;239 Other cerebrovascular diseases Rest (430-438) *;patients discharged per 100,000 inhabitants;Females;200 Other cerebrovascular diseases Rest (430-438) *;average stay by discharge;Both sexes;10.71 Other cerebrovascular diseases Rest (430-438) *;average stay by discharge;Males;10.49 Other cerebrovascular diseases Rest (430-438) *;average stay by discharge;Females;10.96 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;patients discharged per 100,000 inhabitants;Both sexes;83 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;patients discharged per 100,000 inhabitants;Males;121 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;patients discharged per 100,000 inhabitants;Females;46 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;average stay by discharge;Both sexes;10.48 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;average stay by discharge;Males;10.58 DISEASES OF ARTERIES, ARTERIOLES AND CAPILLARIES 440-449 VII.8;average stay by discharge;Females;10.24 Atherosclerosis 440 *;patients discharged per 100,000 inhabitants;Both sexes;38 Atherosclerosis 440 *;patients discharged per 100,000 inhabitants;Males;58 Atherosclerosis 440 *;patients discharged per 100,000 inhabitants;Females;20 Atherosclerosis 440 *;average stay by discharge;Both sexes;11.79 Atherosclerosis 440 *;average stay by discharge;Males;11.68 Atherosclerosis 440 *;average stay by discharge;Females;12.09 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;patients discharged per 100,000 inhabitants;Both sexes;44 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;patients discharged per 100,000 inhabitants;Males;63 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;patients discharged per 100,000 inhabitants;Females;26 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;average stay by discharge;Both sexes;9.35 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;average stay by discharge;Males;9.58 Other diseases of arteries, arterioles and capillaries Rest (440-449) *;average stay by discharge;Females;8.82 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;patients discharged per 100,000 inhabitants;Both sexes;132 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;patients discharged per 100,000 inhabitants;Males;127 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;patients discharged per 100,000 inhabitants;Females;138 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;average stay by discharge;Both sexes;3.17 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;average stay by discharge;Males;3.30 DISEASES OF VEINS AND LYMPHATIC VESSELS AND OTHER DISEASES OF THE CIRCULATORY SYSTEM 451-459 VII.9;average stay by discharge;Females;3.06 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;patients discharged per 100,000 inhabitants;Both sexes;26 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;patients discharged per 100,000 inhabitants;Males;27 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;patients discharged per 100,000 inhabitants;Females;25 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;average stay by discharge;Both sexes;6.61 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;average stay by discharge;Males;6.42 Phlebitis, thrombophlebitis, arterial embolism and thrombosis 451-453;average stay by discharge;Females;6.82 Varicose veins of lower extremities 454;patients discharged per 100,000 inhabitants;Both sexes;48 Varicose veins of lower extremities 454;patients discharged per 100,000 inhabitants;Males;33 Varicose veins of lower extremities 454;patients discharged per 100,000 inhabitants;Females;63 Varicose veins of lower extremities 454;average stay by discharge;Both sexes;1.52 Varicose veins of lower extremities 454;average stay by discharge;Males;1.55 Varicose veins of lower extremities 454;average stay by discharge;Females;1.50 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);patients discharged per 100,000 inhabitants;Both sexes;58 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);patients discharged per 100,000 inhabitants;Males;67 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);patients discharged per 100,000 inhabitants;Females;50 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);average stay by discharge;Both sexes;3.01 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);average stay by discharge;Males;2.92 Other diseases of the veins and lymphatic vessels and other diseases of the circulatory system Rest (451-459);average stay by discharge;Females;3.12 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;patients discharged per 100,000 inhabitants;Both sexes;1,123 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;patients discharged per 100,000 inhabitants;Males;1,332 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;patients discharged per 100,000 inhabitants;Females;921 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;average stay by discharge;Both sexes;6.87 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;average stay by discharge;Males;6.92 DISEASES OF THE RESPIRATORY SYSTEM 460-519 VIII;average stay by discharge;Females;6.79 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;patients discharged per 100,000 inhabitants;Both sexes;288 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;patients discharged per 100,000 inhabitants;Males;326 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;patients discharged per 100,000 inhabitants;Females;251 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;average stay by discharge;Both sexes;3.15 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;average stay by discharge;Males;2.97 ACUTE RESPIRATORY INFECTIONS AND OTHER DISEASES OF THE UPPER RESPIRATORY TRACT 460-478 VIII.1;average stay by discharge;Females;3.37 Bronchitis and acute bronchiolitis 466;patients discharged per 100,000 inhabitants;Both sexes;98 Bronchitis and acute bronchiolitis 466;patients discharged per 100,000 inhabitants;Males;102 Bronchitis and acute bronchiolitis 466;patients discharged per 100,000 inhabitants;Females;95 Bronchitis and acute bronchiolitis 466;average stay by discharge;Both sexes;5.25 Bronchitis and acute bronchiolitis 466;average stay by discharge;Males;5.01 Bronchitis and acute bronchiolitis 466;average stay by discharge;Females;5.50 Chronic diseases of the amygdalas and adenoid vegetations 474;patients discharged per 100,000 inhabitants;Both sexes;60 Chronic diseases of the amygdalas and adenoid vegetations 474;patients discharged per 100,000 inhabitants;Males;65 Chronic diseases of the amygdalas and adenoid vegetations 474;patients discharged per 100,000 inhabitants;Females;55 Chronic diseases of the amygdalas and adenoid vegetations 474;average stay by discharge;Both sexes;1.39 Chronic diseases of the amygdalas and adenoid vegetations 474;average stay by discharge;Males;1.39 Chronic diseases of the amygdalas and adenoid vegetations 474;average stay by discharge;Females;1.39 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);patients discharged per 100,000 inhabitants;Both sexes;130 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);patients discharged per 100,000 inhabitants;Males;160 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);patients discharged per 100,000 inhabitants;Females;101 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);average stay by discharge;Both sexes;2.36 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);average stay by discharge;Males;2.30 Other acute respiratory infections and other diseases of the upper respiratory tract Rest (460-478);average stay by discharge;Females;2.46 PNEUMONIA AND INFLUENZA 480-488 VIII.2;patients discharged per 100,000 inhabitants;Both sexes;259 PNEUMONIA AND INFLUENZA 480-488 VIII.2;patients discharged per 100,000 inhabitants;Males;311 PNEUMONIA AND INFLUENZA 480-488 VIII.2;patients discharged per 100,000 inhabitants;Females;209 PNEUMONIA AND INFLUENZA 480-488 VIII.2;average stay by discharge;Both sexes;8.31 PNEUMONIA AND INFLUENZA 480-488 VIII.2;average stay by discharge;Males;8.39 PNEUMONIA AND INFLUENZA 480-488 VIII.2;average stay by discharge;Females;8.19 Pneumonia 480-486 *;patients discharged per 100,000 inhabitants;Both sexes;250 Pneumonia 480-486 *;patients discharged per 100,000 inhabitants;Males;301 Pneumonia 480-486 *;patients discharged per 100,000 inhabitants;Females;201 Pneumonia 480-486 *;average stay by discharge;Both sexes;8.30 Pneumonia 480-486 *;average stay by discharge;Males;8.37 Pneumonia 480-486 *;average stay by discharge;Females;8.19 Flu 487-488 *;patients discharged per 100,000 inhabitants;Both sexes;8 Flu 487-488 *;patients discharged per 100,000 inhabitants;Males;10 Flu 487-488 *;patients discharged per 100,000 inhabitants;Females;7 Flu 487-488 *;average stay by discharge;Both sexes;8.67 Flu 487-488 *;average stay by discharge;Males;9.14 Flu 487-488 *;average stay by discharge;Females;8.08 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;patients discharged per 100,000 inhabitants;Both sexes;222 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;patients discharged per 100,000 inhabitants;Males;309 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;patients discharged per 100,000 inhabitants;Females;138 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;average stay by discharge;Both sexes;7.64 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;average stay by discharge;Males;7.80 CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED DISEASES 490-496 VIII.3;average stay by discharge;Females;7.30 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;patients discharged per 100,000 inhabitants;Both sexes;171 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;patients discharged per 100,000 inhabitants;Males;276 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;patients discharged per 100,000 inhabitants;Females;70 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;average stay by discharge;Both sexes;8.19 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;average stay by discharge;Males;8.18 Chronic obstructive pulmonary disease and bronchitis 490-492,494,496 *;average stay by discharge;Females;8.23 Asthma 493 *;patients discharged per 100,000 inhabitants;Both sexes;51 Asthma 493 *;patients discharged per 100,000 inhabitants;Males;33 Asthma 493 *;patients discharged per 100,000 inhabitants;Females;68 Asthma 493 *;average stay by discharge;Both sexes;5.76 Asthma 493 *;average stay by discharge;Males;4.57 Asthma 493 *;average stay by discharge;Females;6.32 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);patients discharged per 100,000 inhabitants;Both sexes;0 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);patients discharged per 100,000 inhabitants;Males;0 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);patients discharged per 100,000 inhabitants;Females;0 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);average stay by discharge;Both sexes;8.78 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);average stay by discharge;Males;8.51 Other diseases associated to chronic obstructive pulmonary disease Rest (490-496);average stay by discharge;Females;9.03 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;patients discharged per 100,000 inhabitants;Both sexes;354 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;patients discharged per 100,000 inhabitants;Males;385 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;patients discharged per 100,000 inhabitants;Females;323 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;average stay by discharge;Both sexes;8.35 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;average stay by discharge;Males;8.39 PNEUMOCONIOSIS AND OTHER RESPIRATORY SYSTEM DISEASES 500-519 VIII.4;average stay by discharge;Females;8.31 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;patients discharged per 100,000 inhabitants;Both sexes;1,227 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;patients discharged per 100,000 inhabitants;Males;1,399 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;patients discharged per 100,000 inhabitants;Females;1,060 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;average stay by discharge;Both sexes;5.55 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;average stay by discharge;Males;5.43 DISEASES OF THE DISGESTIVE SYSTEM 520-579 IX;average stay by discharge;Females;5.71 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;patients discharged per 100,000 inhabitants;Both sexes;42 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;patients discharged per 100,000 inhabitants;Males;43 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;patients discharged per 100,000 inhabitants;Females;41 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;average stay by discharge;Both sexes;3.08 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;average stay by discharge;Males;3.18 DISEASES OF ORAL CAVITY, SALIVARY GLANDS AND JAWS 520-529 IX.1;average stay by discharge;Females;2.98 Disorders of the teeth and supporting structures 520-525 *;patients discharged per 100,000 inhabitants;Both sexes;26 Disorders of the teeth and supporting structures 520-525 *;patients discharged per 100,000 inhabitants;Males;25 Disorders of the teeth and supporting structures 520-525 *;patients discharged per 100,000 inhabitants;Females;27 Disorders of the teeth and supporting structures 520-525 *;average stay by discharge;Both sexes;2.44 Disorders of the teeth and supporting structures 520-525 *;average stay by discharge;Males;2.51 Disorders of the teeth and supporting structures 520-525 *;average stay by discharge;Females;2.38 Diseases of the oral cavity, salivary glands and jaws 526-529 *;patients discharged per 100,000 inhabitants;Both sexes;17 Diseases of the oral cavity, salivary glands and jaws 526-529 *;patients discharged per 100,000 inhabitants;Males;19 Diseases of the oral cavity, salivary glands and jaws 526-529 *;patients discharged per 100,000 inhabitants;Females;15 Diseases of the oral cavity, salivary glands and jaws 526-529 *;average stay by discharge;Both sexes;4.07 Diseases of the oral cavity, salivary glands and jaws 526-529 *;average stay by discharge;Males;4.06 Diseases of the oral cavity, salivary glands and jaws 526-529 *;average stay by discharge;Females;4.09 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;patients discharged per 100,000 inhabitants;Both sexes;76 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;patients discharged per 100,000 inhabitants;Males;93 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;patients discharged per 100,000 inhabitants;Females;60 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;average stay by discharge;Both sexes;6.22 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;average stay by discharge;Males;6.32 DISEASES OF THE OESOPHAGUS, STOMACH AND DUODENUM 530-538 IX.2;average stay by discharge;Females;6.08 Diseases of esophagus 530 *;patients discharged per 100,000 inhabitants;Both sexes;24 Diseases of esophagus 530 *;patients discharged per 100,000 inhabitants;Males;31 Diseases of esophagus 530 *;patients discharged per 100,000 inhabitants;Females;18 Diseases of esophagus 530 *;average stay by discharge;Both sexes;5.41 Diseases of esophagus 530 *;average stay by discharge;Males;5.49 Diseases of esophagus 530 *;average stay by discharge;Females;5.29 Ulcers 531-534 *;patients discharged per 100,000 inhabitants;Both sexes;24 Ulcers 531-534 *;patients discharged per 100,000 inhabitants;Males;34 Ulcers 531-534 *;patients discharged per 100,000 inhabitants;Females;14 Ulcers 531-534 *;average stay by discharge;Both sexes;7.34 Ulcers 531-534 *;average stay by discharge;Males;7.11 Ulcers 531-534 *;average stay by discharge;Females;7.90 Gastritis and other diseases of the stomach and duodenum 535-538 *;patients discharged per 100,000 inhabitants;Both sexes;28 Gastritis and other diseases of the stomach and duodenum 535-538 *;patients discharged per 100,000 inhabitants;Males;28 Gastritis and other diseases of the stomach and duodenum 535-538 *;patients discharged per 100,000 inhabitants;Females;27 Gastritis and other diseases of the stomach and duodenum 535-538 *;average stay by discharge;Both sexes;5.96 Gastritis and other diseases of the stomach and duodenum 535-538 *;average stay by discharge;Males;6.26 Gastritis and other diseases of the stomach and duodenum 535-538 *;average stay by discharge;Females;5.66 APPENDICITIS 540-543 IX.3;patients discharged per 100,000 inhabitants;Both sexes;107 APPENDICITIS 540-543 IX.3;patients discharged per 100,000 inhabitants;Males;125 APPENDICITIS 540-543 IX.3;patients discharged per 100,000 inhabitants;Females;90 APPENDICITIS 540-543 IX.3;average stay by discharge;Both sexes;3.81 APPENDICITIS 540-543 IX.3;average stay by discharge;Males;3.87 APPENDICITIS 540-543 IX.3;average stay by discharge;Females;3.74 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;patients discharged per 100,000 inhabitants;Both sexes;232 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;patients discharged per 100,000 inhabitants;Males;336 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;patients discharged per 100,000 inhabitants;Females;133 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;average stay by discharge;Both sexes;2.47 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;average stay by discharge;Males;2.08 HERNIA OF THE ABDOMINAL CAVITY 550-553 IX.4;average stay by discharge;Females;3.43 Inguinal hernia 550 *;patients discharged per 100,000 inhabitants;Both sexes;134 Inguinal hernia 550 *;patients discharged per 100,000 inhabitants;Males;240 Inguinal hernia 550 *;patients discharged per 100,000 inhabitants;Females;31 Inguinal hernia 550 *;average stay by discharge;Both sexes;1.64 Inguinal hernia 550 *;average stay by discharge;Males;1.63 Inguinal hernia 550 *;average stay by discharge;Females;1.71 Other hernia of abdominal cavity 551-553 *;patients discharged per 100,000 inhabitants;Both sexes;99 Other hernia of abdominal cavity 551-553 *;patients discharged per 100,000 inhabitants;Males;96 Other hernia of abdominal cavity 551-553 *;patients discharged per 100,000 inhabitants;Females;102 Other hernia of abdominal cavity 551-553 *;average stay by discharge;Both sexes;3.60 Other hernia of abdominal cavity 551-553 *;average stay by discharge;Males;3.21 Other hernia of abdominal cavity 551-553 *;average stay by discharge;Females;3.95 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;patients discharged per 100,000 inhabitants;Both sexes;326 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;patients discharged per 100,000 inhabitants;Males;349 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;patients discharged per 100,000 inhabitants;Females;302 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;average stay by discharge;Both sexes;6.60 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;average stay by discharge;Males;6.42 NON INFECTIOUS ENTERITIS AND COLITIS AND OTHER DISEASES OF THE INTESTINE AND PERITONEUM 555-569 IX.5;average stay by discharge;Females;6.81 Regional enteritis and Crohn's disease 555-556 *;patients discharged per 100,000 inhabitants;Both sexes;24 Regional enteritis and Crohn's disease 555-556 *;patients discharged per 100,000 inhabitants;Males;26 Regional enteritis and Crohn's disease 555-556 *;patients discharged per 100,000 inhabitants;Females;22 Regional enteritis and Crohn's disease 555-556 *;average stay by discharge;Both sexes;9.89 Regional enteritis and Crohn's disease 555-556 *;average stay by discharge;Males;9.91 Regional enteritis and Crohn's disease 555-556 *;average stay by discharge;Females;9.87 Other noninfectious gastroenteritis and colitis 558 *;patients discharged per 100,000 inhabitants;Both sexes;72 Other noninfectious gastroenteritis and colitis 558 *;patients discharged per 100,000 inhabitants;Males;69 Other noninfectious gastroenteritis and colitis 558 *;patients discharged per 100,000 inhabitants;Females;75 Other noninfectious gastroenteritis and colitis 558 *;average stay by discharge;Both sexes;4.36 Other noninfectious gastroenteritis and colitis 558 *;average stay by discharge;Males;4.23 Other noninfectious gastroenteritis and colitis 558 *;average stay by discharge;Females;4.47 Intestinal obstruction without mention of hernia 560 *;patients discharged per 100,000 inhabitants;Both sexes;55 Intestinal obstruction without mention of hernia 560 *;patients discharged per 100,000 inhabitants;Males;58 Intestinal obstruction without mention of hernia 560 *;patients discharged per 100,000 inhabitants;Females;53 Intestinal obstruction without mention of hernia 560 *;average stay by discharge;Both sexes;8.51 Intestinal obstruction without mention of hernia 560 *;average stay by discharge;Males;8.36 Intestinal obstruction without mention of hernia 560 *;average stay by discharge;Females;8.66 Diverticula of intestine 562 *;patients discharged per 100,000 inhabitants;Both sexes;44 Diverticula of intestine 562 *;patients discharged per 100,000 inhabitants;Males;45 Diverticula of intestine 562 *;patients discharged per 100,000 inhabitants;Females;44 Diverticula of intestine 562 *;average stay by discharge;Both sexes;7.85 Diverticula of intestine 562 *;average stay by discharge;Males;7.67 Diverticula of intestine 562 *;average stay by discharge;Females;8.03 Other disorders of intestine and peritoneum Rest (555-569) *;patients discharged per 100,000 inhabitants;Both sexes;130 Other disorders of intestine and peritoneum Rest (555-569) *;patients discharged per 100,000 inhabitants;Males;152 Other disorders of intestine and peritoneum Rest (555-569) *;patients discharged per 100,000 inhabitants;Females;108 Other disorders of intestine and peritoneum Rest (555-569) *;average stay by discharge;Both sexes;6.00 Other disorders of intestine and peritoneum Rest (555-569) *;average stay by discharge;Males;5.70 Other disorders of intestine and peritoneum Rest (555-569) *;average stay by discharge;Females;6.41 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;patients discharged per 100,000 inhabitants;Both sexes;443 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;patients discharged per 100,000 inhabitants;Males;453 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;patients discharged per 100,000 inhabitants;Females;434 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;average stay by discharge;Both sexes;6.94 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;average stay by discharge;Males;7.60 OTHER DIGESTIVE SYSTEM DISEASES 570-579 IX.6;average stay by discharge;Females;6.26 Diseases of liver and chronic cirrhosis of liver 571;patients discharged per 100,000 inhabitants;Both sexes;41 Diseases of liver and chronic cirrhosis of liver 571;patients discharged per 100,000 inhabitants;Males;59 Diseases of liver and chronic cirrhosis of liver 571;patients discharged per 100,000 inhabitants;Females;23 Diseases of liver and chronic cirrhosis of liver 571;average stay by discharge;Both sexes;9.32 Diseases of liver and chronic cirrhosis of liver 571;average stay by discharge;Males;9.34 Diseases of liver and chronic cirrhosis of liver 571;average stay by discharge;Females;9.26 Cholelithiasis 574 *;patients discharged per 100,000 inhabitants;Both sexes;218 Cholelithiasis 574 *;patients discharged per 100,000 inhabitants;Males;182 Cholelithiasis 574 *;patients discharged per 100,000 inhabitants;Females;253 Cholelithiasis 574 *;average stay by discharge;Both sexes;5.14 Cholelithiasis 574 *;average stay by discharge;Males;5.77 Cholelithiasis 574 *;average stay by discharge;Females;4.70 Other disorders of gallbladder and biliary tract 575-576 *;patients discharged per 100,000 inhabitants;Both sexes;54 Other disorders of gallbladder and biliary tract 575-576 *;patients discharged per 100,000 inhabitants;Males;59 Other disorders of gallbladder and biliary tract 575-576 *;patients discharged per 100,000 inhabitants;Females;49 Other disorders of gallbladder and biliary tract 575-576 *;average stay by discharge;Both sexes;7.91 Other disorders of gallbladder and biliary tract 575-576 *;average stay by discharge;Males;8.31 Other disorders of gallbladder and biliary tract 575-576 *;average stay by discharge;Females;7.45 Diseases of pancreas 577 *;patients discharged per 100,000 inhabitants;Both sexes;65 Diseases of pancreas 577 *;patients discharged per 100,000 inhabitants;Males;74 Diseases of pancreas 577 *;patients discharged per 100,000 inhabitants;Females;57 Diseases of pancreas 577 *;average stay by discharge;Both sexes;9.77 Diseases of pancreas 577 *;average stay by discharge;Males;9.90 Diseases of pancreas 577 *;average stay by discharge;Females;9.61 Other Diseases of the Digestive System Rest (570-579);patients discharged per 100,000 inhabitants;Both sexes;64 Other Diseases of the Digestive System Rest (570-579);patients discharged per 100,000 inhabitants;Males;78 Other Diseases of the Digestive System Rest (570-579);patients discharged per 100,000 inhabitants;Females;51 Other Diseases of the Digestive System Rest (570-579);average stay by discharge;Both sexes;7.82 Other Diseases of the Digestive System Rest (570-579);average stay by discharge;Males;7.84 Other Diseases of the Digestive System Rest (570-579);average stay by discharge;Females;7.79 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;patients discharged per 100,000 inhabitants;Both sexes;632 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;patients discharged per 100,000 inhabitants;Males;581 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;patients discharged per 100,000 inhabitants;Females;682 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;average stay by discharge;Both sexes;4.86 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;average stay by discharge;Males;5.32 DISEASES OF THE GENITO-URINARY SYSTEM 580-629 X;average stay by discharge;Females;4.47 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;patients discharged per 100,000 inhabitants;Both sexes;64 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;patients discharged per 100,000 inhabitants;Males;74 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;patients discharged per 100,000 inhabitants;Females;54 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;average stay by discharge;Both sexes;8.96 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;average stay by discharge;Males;8.87 NEPHRITIS, NEPHROTIC SYNDROME AND NEPHROSIS 580-589 X.1;average stay by discharge;Females;9.07 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;patients discharged per 100,000 inhabitants;Both sexes;276 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;patients discharged per 100,000 inhabitants;Males;293 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;patients discharged per 100,000 inhabitants;Females;259 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;average stay by discharge;Both sexes;5.76 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;average stay by discharge;Males;5.51 OTHER DISEASES OF THE GENITOURINARY SYSTEM 590-599 X.2;average stay by discharge;Females;6.02 Urinary calculus 592.594;patients discharged per 100,000 inhabitants;Both sexes;55 Urinary calculus 592.594;patients discharged per 100,000 inhabitants;Males;68 Urinary calculus 592.594;patients discharged per 100,000 inhabitants;Females;42 Urinary calculus 592.594;average stay by discharge;Both sexes;3.74 Urinary calculus 592.594;average stay by discharge;Males;3.63 Urinary calculus 592.594;average stay by discharge;Females;3.93 Other diseases of the urinary system Rest (590-599);patients discharged per 100,000 inhabitants;Both sexes;221 Other diseases of the urinary system Rest (590-599);patients discharged per 100,000 inhabitants;Males;225 Other diseases of the urinary system Rest (590-599);patients discharged per 100,000 inhabitants;Females;217 Other diseases of the urinary system Rest (590-599);average stay by discharge;Both sexes;6.26 Other diseases of the urinary system Rest (590-599);average stay by discharge;Males;6.08 Other diseases of the urinary system Rest (590-599);average stay by discharge;Females;6.43 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;patients discharged per 100,000 inhabitants;Both sexes;100 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;patients discharged per 100,000 inhabitants;Males;204 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;patients discharged per 100,000 inhabitants;Females;.. OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;average stay by discharge;Both sexes;3.93 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;average stay by discharge;Males;3.93 OTHER MALE GENITAL ORGANS DISEASES 600-608 X.3;average stay by discharge;Females;.. Hyperplasia of prostate 600;patients discharged per 100,000 inhabitants;Both sexes;53 Hyperplasia of prostate 600;patients discharged per 100,000 inhabitants;Males;107 Hyperplasia of prostate 600;patients discharged per 100,000 inhabitants;Females;.. Hyperplasia of prostate 600;average stay by discharge;Both sexes;4.84 Hyperplasia of prostate 600;average stay by discharge;Males;4.84 Hyperplasia of prostate 600;average stay by discharge;Females;.. Other male genital organs diseases (600-608), Rest;patients discharged per 100,000 inhabitants;Both sexes;48 Other male genital organs diseases (600-608), Rest;patients discharged per 100,000 inhabitants;Males;97 Other male genital organs diseases (600-608), Rest;patients discharged per 100,000 inhabitants;Females;.. Other male genital organs diseases (600-608), Rest;average stay by discharge;Both sexes;2.92 Other male genital organs diseases (600-608), Rest;average stay by discharge;Males;2.92 Other male genital organs diseases (600-608), Rest;average stay by discharge;Females;.. BREAST DISORDERS 610-612 X.4;patients discharged per 100,000 inhabitants;Both sexes;39 BREAST DISORDERS 610-612 X.4;patients discharged per 100,000 inhabitants;Males;10 BREAST DISORDERS 610-612 X.4;patients discharged per 100,000 inhabitants;Females;67 BREAST DISORDERS 610-612 X.4;average stay by discharge;Both sexes;1.70 BREAST DISORDERS 610-612 X.4;average stay by discharge;Males;1.72 BREAST DISORDERS 610-612 X.4;average stay by discharge;Females;1.69 DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;patients discharged per 100,000 inhabitants;Both sexes;153 DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;patients discharged per 100,000 inhabitants;Males;.. DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;patients discharged per 100,000 inhabitants;Females;302 DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;average stay by discharge;Both sexes;2.94 DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;average stay by discharge;Males;.. DISEASES OF THE FEMALE PELVIC AND GENITAL ORGANS 614-629 X.5;average stay by discharge;Females;2.94 Inflammatory diseases of female pelvic organs 614-616 *;patients discharged per 100,000 inhabitants;Both sexes;19 Inflammatory diseases of female pelvic organs 614-616 *;patients discharged per 100,000 inhabitants;Males;.. Inflammatory diseases of female pelvic organs 614-616 *;patients discharged per 100,000 inhabitants;Females;37 Inflammatory diseases of female pelvic organs 614-616 *;average stay by discharge;Both sexes;3.74 Inflammatory diseases of female pelvic organs 614-616 *;average stay by discharge;Males;.. Inflammatory diseases of female pelvic organs 614-616 *;average stay by discharge;Females;3.74 Other diseases of the female pelvic and genital organs Rest (614-629);patients discharged per 100,000 inhabitants;Both sexes;135 Other diseases of the female pelvic and genital organs Rest (614-629);patients discharged per 100,000 inhabitants;Males;.. Other diseases of the female pelvic and genital organs Rest (614-629);patients discharged per 100,000 inhabitants;Females;265 Other diseases of the female pelvic and genital organs Rest (614-629);average stay by discharge;Both sexes;2.83 Other diseases of the female pelvic and genital organs Rest (614-629);average stay by discharge;Males;.. Other diseases of the female pelvic and genital organs Rest (614-629);average stay by discharge;Females;2.83 COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;patients discharged per 100,000 inhabitants;Both sexes;1,198 COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;patients discharged per 100,000 inhabitants;Males;.. COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;patients discharged per 100,000 inhabitants;Females;2,357 COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;average stay by discharge;Both sexes;2.99 COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;average stay by discharge;Males;.. COMPLICATIONS DURING PREGNANCY, CHILDBIRTH AND THE PUERPERIUM 630-679 XI;average stay by discharge;Females;2.99 ABORTION 630-639 XI.1;patients discharged per 100,000 inhabitants;Both sexes;87 ABORTION 630-639 XI.1;patients discharged per 100,000 inhabitants;Males;.. ABORTION 630-639 XI.1;patients discharged per 100,000 inhabitants;Females;171 ABORTION 630-639 XI.1;average stay by discharge;Both sexes;1.70 ABORTION 630-639 XI.1;average stay by discharge;Males;.. ABORTION 630-639 XI.1;average stay by discharge;Females;1.70 Legally induced abortion 635 *;patients discharged per 100,000 inhabitants;Both sexes;5 Legally induced abortion 635 *;patients discharged per 100,000 inhabitants;Males;.. Legally induced abortion 635 *;patients discharged per 100,000 inhabitants;Females;10 Legally induced abortion 635 *;average stay by discharge;Both sexes;1.79 Legally induced abortion 635 *;average stay by discharge;Males;.. Legally induced abortion 635 *;average stay by discharge;Females;1.79 Other pregnancies ending in abortion Rest (630-639) *;patients discharged per 100,000 inhabitants;Both sexes;81 Other pregnancies ending in abortion Rest (630-639) *;patients discharged per 100,000 inhabitants;Males;.. Other pregnancies ending in abortion Rest (630-639) *;patients discharged per 100,000 inhabitants;Females;160 Other pregnancies ending in abortion Rest (630-639) *;average stay by discharge;Both sexes;1.69 Other pregnancies ending in abortion Rest (630-639) *;average stay by discharge;Males;.. Other pregnancies ending in abortion Rest (630-639) *;average stay by discharge;Females;1.69 COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;patients discharged per 100,000 inhabitants;Both sexes;343 COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;patients discharged per 100,000 inhabitants;Males;.. COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;patients discharged per 100,000 inhabitants;Females;675 COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;average stay by discharge;Both sexes;3.11 COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;average stay by discharge;Males;.. COMPLICATIONS MAINLY RELATED TO THE PREGNANCY 640-649 XI.2;average stay by discharge;Females;3.11 NORMAL BIRTH 650 XI.3;patients discharged per 100,000 inhabitants;Both sexes;105 NORMAL BIRTH 650 XI.3;patients discharged per 100,000 inhabitants;Males;.. NORMAL BIRTH 650 XI.3;patients discharged per 100,000 inhabitants;Females;207 NORMAL BIRTH 650 XI.3;average stay by discharge;Both sexes;2.46 NORMAL BIRTH 650 XI.3;average stay by discharge;Males;.. NORMAL BIRTH 650 XI.3;average stay by discharge;Females;2.46 CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;patients discharged per 100,000 inhabitants;Both sexes;392 CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;patients discharged per 100,000 inhabitants;Males;.. CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;patients discharged per 100,000 inhabitants;Females;772 CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;average stay by discharge;Both sexes;3.26 CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;average stay by discharge;Males;.. CARE DURING THE PREGNANCY, LABOUR AND DELIVERY 651-659 XI.4;average stay by discharge;Females;3.26 COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;patients discharged per 100,000 inhabitants;Both sexes;261 COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;patients discharged per 100,000 inhabitants;Males;.. COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;patients discharged per 100,000 inhabitants;Females;514 COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;average stay by discharge;Both sexes;3.06 COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;average stay by discharge;Males;.. COMPLICATIONS DURING THE DELIVERY 660-669 XI.5;average stay by discharge;Females;3.06 COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;patients discharged per 100,000 inhabitants;Both sexes;10 COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;patients discharged per 100,000 inhabitants;Males;.. COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;patients discharged per 100,000 inhabitants;Females;19 COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;average stay by discharge;Both sexes;3.60 COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;average stay by discharge;Males;.. COMPLICATIONS OF THE PUERPERIUM 670-679 XI.6;average stay by discharge;Females;3.60 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;patients discharged per 100,000 inhabitants;Both sexes;103 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;patients discharged per 100,000 inhabitants;Males;113 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;patients discharged per 100,000 inhabitants;Females;93 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;average stay by discharge;Both sexes;7.76 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;average stay by discharge;Males;7.07 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE 680-709 XII;average stay by discharge;Females;8.57 Infections of skin and subcutaneous cellular tissue 680-686 *;patients discharged per 100,000 inhabitants;Both sexes;63 Infections of skin and subcutaneous cellular tissue 680-686 *;patients discharged per 100,000 inhabitants;Males;76 Infections of skin and subcutaneous cellular tissue 680-686 *;patients discharged per 100,000 inhabitants;Females;51 Infections of skin and subcutaneous cellular tissue 680-686 *;average stay by discharge;Both sexes;5.73 Infections of skin and subcutaneous cellular tissue 680-686 *;average stay by discharge;Males;5.05 Infections of skin and subcutaneous cellular tissue 680-686 *;average stay by discharge;Females;6.72 Other diseases of skin and subcutaneous tissue Rest (680-709) *;patients discharged per 100,000 inhabitants;Both sexes;40 Other diseases of skin and subcutaneous tissue Rest (680-709) *;patients discharged per 100,000 inhabitants;Males;38 Other diseases of skin and subcutaneous tissue Rest (680-709) *;patients discharged per 100,000 inhabitants;Females;43 Other diseases of skin and subcutaneous tissue Rest (680-709) *;average stay by discharge;Both sexes;10.92 Other diseases of skin and subcutaneous tissue Rest (680-709) *;average stay by discharge;Males;11.10 Other diseases of skin and subcutaneous tissue Rest (680-709) *;average stay by discharge;Females;10.76 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;patients discharged per 100,000 inhabitants;Both sexes;730 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;patients discharged per 100,000 inhabitants;Males;709 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;patients discharged per 100,000 inhabitants;Females;749 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;average stay by discharge;Both sexes;4.59 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;average stay by discharge;Males;4.27 DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE 710-739 XIII;average stay by discharge;Females;4.88 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;patients discharged per 100,000 inhabitants;Both sexes;373 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;patients discharged per 100,000 inhabitants;Males;375 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;patients discharged per 100,000 inhabitants;Females;370 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;average stay by discharge;Both sexes;4.67 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;average stay by discharge;Males;3.89 ARTHROPATHIES AND RELATED DISORDERS 710-719 XIII.1;average stay by discharge;Females;5.42 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;patients discharged per 100,000 inhabitants;Both sexes;4 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;patients discharged per 100,000 inhabitants;Males;3 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;patients discharged per 100,000 inhabitants;Females;6 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;average stay by discharge;Both sexes;8.71 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;average stay by discharge;Males;9.27 Rheumatoid arthritis, and other inflammatory polyarthropathies 714;average stay by discharge;Females;8.42 Internal derangement of knee 717 *;patients discharged per 100,000 inhabitants;Both sexes;112 Internal derangement of knee 717 *;patients discharged per 100,000 inhabitants;Males;155 Internal derangement of knee 717 *;patients discharged per 100,000 inhabitants;Females;71 Internal derangement of knee 717 *;average stay by discharge;Both sexes;1.51 Internal derangement of knee 717 *;average stay by discharge;Males;1.53 Internal derangement of knee 717 *;average stay by discharge;Females;1.45 Other arthropathies and related disorders Rest (710-719);patients discharged per 100,000 inhabitants;Both sexes;256 Other arthropathies and related disorders Rest (710-719);patients discharged per 100,000 inhabitants;Males;217 Other arthropathies and related disorders Rest (710-719);patients discharged per 100,000 inhabitants;Females;293 Other arthropathies and related disorders Rest (710-719);average stay by discharge;Both sexes;5.98 Other arthropathies and related disorders Rest (710-719);average stay by discharge;Males;5.49 Other arthropathies and related disorders Rest (710-719);average stay by discharge;Females;6.33 DORSOPATHIES 720-724 XIII.2;patients discharged per 100,000 inhabitants;Both sexes;126 DORSOPATHIES 720-724 XIII.2;patients discharged per 100,000 inhabitants;Males;132 DORSOPATHIES 720-724 XIII.2;patients discharged per 100,000 inhabitants;Females;119 DORSOPATHIES 720-724 XIII.2;average stay by discharge;Both sexes;5.81 DORSOPATHIES 720-724 XIII.2;average stay by discharge;Males;5.73 DORSOPATHIES 720-724 XIII.2;average stay by discharge;Females;5.90 Intervertebral disc disorders 722 *;patients discharged per 100,000 inhabitants;Both sexes;71 Intervertebral disc disorders 722 *;patients discharged per 100,000 inhabitants;Males;78 Intervertebral disc disorders 722 *;patients discharged per 100,000 inhabitants;Females;63 Intervertebral disc disorders 722 *;average stay by discharge;Both sexes;5.51 Intervertebral disc disorders 722 *;average stay by discharge;Males;5.42 Intervertebral disc disorders 722 *;average stay by discharge;Females;5.61 Other back disorders Rest (720-724) *;patients discharged per 100,000 inhabitants;Both sexes;55 Other back disorders Rest (720-724) *;patients discharged per 100,000 inhabitants;Males;54 Other back disorders Rest (720-724) *;patients discharged per 100,000 inhabitants;Females;56 Other back disorders Rest (720-724) *;average stay by discharge;Both sexes;6.21 Other back disorders Rest (720-724) *;average stay by discharge;Males;6.18 Other back disorders Rest (720-724) *;average stay by discharge;Females;6.23 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;patients discharged per 100,000 inhabitants;Both sexes;110 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;patients discharged per 100,000 inhabitants;Males;117 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;patients discharged per 100,000 inhabitants;Females;104 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;average stay by discharge;Both sexes;2.99 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;average stay by discharge;Males;2.92 RHEUMATISM, EXCLUDING THE BACK 725-729 XIII.3;average stay by discharge;Females;3.07 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;patients discharged per 100,000 inhabitants;Both sexes;121 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;patients discharged per 100,000 inhabitants;Males;86 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;patients discharged per 100,000 inhabitants;Females;155 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;average stay by discharge;Both sexes;4.53 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;average stay by discharge;Males;5.54 OSTEOPATHIES, CHONDROPATHIES AND ACQUIRED MUSCULOSKELETAL DEFORMITIES 730-739 XIII.4;average stay by discharge;Females;4.00 Deformations of the limbs 734-736;patients discharged per 100,000 inhabitants;Both sexes;61 Deformations of the limbs 734-736;patients discharged per 100,000 inhabitants;Males;23 Deformations of the limbs 734-736;patients discharged per 100,000 inhabitants;Females;98 Deformations of the limbs 734-736;average stay by discharge;Both sexes;1.91 Deformations of the limbs 734-736;average stay by discharge;Males;2.57 Deformations of the limbs 734-736;average stay by discharge;Females;1.76 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);patients discharged per 100,000 inhabitants;Both sexes;60 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);patients discharged per 100,000 inhabitants;Males;63 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);patients discharged per 100,000 inhabitants;Females;58 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);average stay by discharge;Both sexes;7.19 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);average stay by discharge;Males;6.62 Osteopathies, chondropathies and acquired musculoskeletal deformities Rest (730-739);average stay by discharge;Females;7.78 CONGENITAL ABNORMALITIES 740-759 XIV;patients discharged per 100,000 inhabitants;Both sexes;88 CONGENITAL ABNORMALITIES 740-759 XIV;patients discharged per 100,000 inhabitants;Males;100 CONGENITAL ABNORMALITIES 740-759 XIV;patients discharged per 100,000 inhabitants;Females;77 CONGENITAL ABNORMALITIES 740-759 XIV;average stay by discharge;Both sexes;4.65 CONGENITAL ABNORMALITIES 740-759 XIV;average stay by discharge;Males;4.75 CONGENITAL ABNORMALITIES 740-759 XIV;average stay by discharge;Females;4.52 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;patients discharged per 100,000 inhabitants;Both sexes;148 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;patients discharged per 100,000 inhabitants;Males;166 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;patients discharged per 100,000 inhabitants;Females;131 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;average stay by discharge;Both sexes;8.85 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;average stay by discharge;Males;8.72 CERTAIN DISEASES ORIGINATING IN THE PERINATAL PERIOD 760-779 XV;average stay by discharge;Females;9.02 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;patients discharged per 100,000 inhabitants;Both sexes;10 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;patients discharged per 100,000 inhabitants;Males;11 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;patients discharged per 100,000 inhabitants;Females;10 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;average stay by discharge;Both sexes;3.46 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;average stay by discharge;Males;3.46 MATERNAL CAUSES OF PERINATAL MORBIDITY AND MORTALITY 760-763 XV.1;average stay by discharge;Females;3.46 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;patients discharged per 100,000 inhabitants;Both sexes;138 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;patients discharged per 100,000 inhabitants;Males;155 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;patients discharged per 100,000 inhabitants;Females;121 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;average stay by discharge;Both sexes;9.25 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;average stay by discharge;Males;9.09 OTHER DISEASES ORIGINATING IN THE PERINATAL PERIOD (EXCEPT CONGENITAL RUBELLA AND NEONATAL TETANUS) 764-779 XV.2;average stay by discharge;Females;9.47 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;patients discharged per 100,000 inhabitants;Both sexes;51 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;patients discharged per 100,000 inhabitants;Males;54 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;patients discharged per 100,000 inhabitants;Females;48 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;average stay by discharge;Both sexes;16.80 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;average stay by discharge;Males;16.90 Slow fetal growth, fetal malnutrition and fetal immaturity 764-765;average stay by discharge;Females;16.70 Other diseases originated in the perinatal period Rest (764-779);patients discharged per 100,000 inhabitants;Both sexes;87 Other diseases originated in the perinatal period Rest (764-779);patients discharged per 100,000 inhabitants;Males;101 Other diseases originated in the perinatal period Rest (764-779);patients discharged per 100,000 inhabitants;Females;73 Other diseases originated in the perinatal period Rest (764-779);average stay by discharge;Both sexes;4.82 Other diseases originated in the perinatal period Rest (764-779);average stay by discharge;Males;4.91 Other diseases originated in the perinatal period Rest (764-779);average stay by discharge;Females;4.70 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;patients discharged per 100,000 inhabitants;Both sexes;424 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;patients discharged per 100,000 inhabitants;Males;458 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;patients discharged per 100,000 inhabitants;Females;392 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;average stay by discharge;Both sexes;4.74 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;average stay by discharge;Males;4.69 SYMPTOMS, SIGNS AND POORLY DEFINED STATES 780-799 XVI;average stay by discharge;Females;4.81 INJURIES AND POISONING 800-999 XVII;patients discharged per 100,000 inhabitants;Both sexes;870 INJURIES AND POISONING 800-999 XVII;patients discharged per 100,000 inhabitants;Males;921 INJURIES AND POISONING 800-999 XVII;patients discharged per 100,000 inhabitants;Females;821 INJURIES AND POISONING 800-999 XVII;average stay by discharge;Both sexes;7.77 INJURIES AND POISONING 800-999 XVII;average stay by discharge;Males;7.17 INJURIES AND POISONING 800-999 XVII;average stay by discharge;Females;8.41 FRACTURES 800-829 XVII.1;patients discharged per 100,000 inhabitants;Both sexes;418 FRACTURES 800-829 XVII.1;patients discharged per 100,000 inhabitants;Males;386 FRACTURES 800-829 XVII.1;patients discharged per 100,000 inhabitants;Females;449 FRACTURES 800-829 XVII.1;average stay by discharge;Both sexes;8.12 FRACTURES 800-829 XVII.1;average stay by discharge;Males;7.26 FRACTURES 800-829 XVII.1;average stay by discharge;Females;8.83 Fracture of the cranium 800-804;patients discharged per 100,000 inhabitants;Both sexes;25 Fracture of the cranium 800-804;patients discharged per 100,000 inhabitants;Males;37 Fracture of the cranium 800-804;patients discharged per 100,000 inhabitants;Females;13 Fracture of the cranium 800-804;average stay by discharge;Both sexes;7.27 Fracture of the cranium 800-804;average stay by discharge;Males;7.36 Fracture of the cranium 800-804;average stay by discharge;Females;7.04 Fractures of the neck and trunk 805-809;patients discharged per 100,000 inhabitants;Both sexes;51 Fractures of the neck and trunk 805-809;patients discharged per 100,000 inhabitants;Males;53 Fractures of the neck and trunk 805-809;patients discharged per 100,000 inhabitants;Females;50 Fractures of the neck and trunk 805-809;average stay by discharge;Both sexes;9.97 Fractures of the neck and trunk 805-809;average stay by discharge;Males;10.58 Fractures of the neck and trunk 805-809;average stay by discharge;Females;9.34 Fracture of radius & ulna 813 *;patients discharged per 100,000 inhabitants;Both sexes;53 Fracture of radius & ulna 813 *;patients discharged per 100,000 inhabitants;Males;54 Fracture of radius & ulna 813 *;patients discharged per 100,000 inhabitants;Females;53 Fracture of radius & ulna 813 *;average stay by discharge;Both sexes;2.98 Fracture of radius & ulna 813 *;average stay by discharge;Males;3.02 Fracture of radius & ulna 813 *;average stay by discharge;Females;2.94 Other fractures involving an upper limb 810-812.814-819 *;patients discharged per 100,000 inhabitants;Both sexes;63 Other fractures involving an upper limb 810-812.814-819 *;patients discharged per 100,000 inhabitants;Males;70 Other fractures involving an upper limb 810-812.814-819 *;patients discharged per 100,000 inhabitants;Females;56 Other fractures involving an upper limb 810-812.814-819 *;average stay by discharge;Both sexes;4.31 Other fractures involving an upper limb 810-812.814-819 *;average stay by discharge;Males;3.64 Other fractures involving an upper limb 810-812.814-819 *;average stay by discharge;Females;5.12 Fractures of the femur 820-821 *;patients discharged per 100,000 inhabitants;Both sexes;143 Fractures of the femur 820-821 *;patients discharged per 100,000 inhabitants;Males;81 Fractures of the femur 820-821 *;patients discharged per 100,000 inhabitants;Females;203 Fractures of the femur 820-821 *;average stay by discharge;Both sexes;12.48 Fractures of the femur 820-821 *;average stay by discharge;Males;12.51 Fractures of the femur 820-821 *;average stay by discharge;Females;12.47 Fracture of tibia & fibula, fracture of ankle 823-824 *;patients discharged per 100,000 inhabitants;Both sexes;66 Fracture of tibia & fibula, fracture of ankle 823-824 *;patients discharged per 100,000 inhabitants;Males;71 Fracture of tibia & fibula, fracture of ankle 823-824 *;patients discharged per 100,000 inhabitants;Females;61 Fracture of tibia & fibula, fracture of ankle 823-824 *;average stay by discharge;Both sexes;6.00 Fracture of tibia & fibula, fracture of ankle 823-824 *;average stay by discharge;Males;6.02 Fracture of tibia & fibula, fracture of ankle 823-824 *;average stay by discharge;Females;5.98 Other fractures involving a lower limb 822.825-829 *;patients discharged per 100,000 inhabitants;Both sexes;17 Other fractures involving a lower limb 822.825-829 *;patients discharged per 100,000 inhabitants;Males;21 Other fractures involving a lower limb 822.825-829 *;patients discharged per 100,000 inhabitants;Females;13 Other fractures involving a lower limb 822.825-829 *;average stay by discharge;Both sexes;5.57 Other fractures involving a lower limb 822.825-829 *;average stay by discharge;Males;5.59 Other fractures involving a lower limb 822.825-829 *;average stay by discharge;Females;5.55 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;patients discharged per 100,000 inhabitants;Both sexes;60 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;patients discharged per 100,000 inhabitants;Males;85 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;patients discharged per 100,000 inhabitants;Females;36 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;average stay by discharge;Both sexes;2.30 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;average stay by discharge;Males;2.22 DISLOCATIONS, SPRAINS AND STRAINS OF JOINTS AND ADJACENT MUSCLES 830-848 XVII.2;average stay by discharge;Females;2.50 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;patients discharged per 100,000 inhabitants;Both sexes;64 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;patients discharged per 100,000 inhabitants;Males;80 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;patients discharged per 100,000 inhabitants;Females;49 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;average stay by discharge;Both sexes;8.47 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;average stay by discharge;Males;8.65 INTERNAL TRAUMAS AND COMPLICATIONS THEREOF (INCLUDES INTRACRANIAL AND NERVES) 850-854,860-869,950-959 XVII.3;average stay by discharge;Females;8.18 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;patients discharged per 100,000 inhabitants;Both sexes;36 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;patients discharged per 100,000 inhabitants;Males;55 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;patients discharged per 100,000 inhabitants;Females;18 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;average stay by discharge;Both sexes;4.57 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;average stay by discharge;Males;4.39 OPEN WOUND OF HEAD, NECK, trunk, upper limbs, lower limbs and Injury of blood vessels, 870-904 XVII.4;average stay by discharge;Females;5.09 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;patients discharged per 100,000 inhabitants;Both sexes;31 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;patients discharged per 100,000 inhabitants;Males;35 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;patients discharged per 100,000 inhabitants;Females;27 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;average stay by discharge;Both sexes;5.05 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;average stay by discharge;Males;4.68 SEQUELAE, SUPERFICIAL INJURIES, CONTUSIONS, CRUSHING INJURIES AND EFFECTS OF FOREIGN BODIES 905-939 XVII.5;average stay by discharge;Females;5.53 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;patients discharged per 100,000 inhabitants;Both sexes;3 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;patients discharged per 100,000 inhabitants;Males;4 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;patients discharged per 100,000 inhabitants;Females;3 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;average stay by discharge;Both sexes;6.05 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;average stay by discharge;Males;5.27 Late effects of injuries, poisining, toxic effects and other external causes 905-909 *;average stay by discharge;Females;7.16 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;patients discharged per 100,000 inhabitants;Both sexes;28 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;patients discharged per 100,000 inhabitants;Males;31 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;patients discharged per 100,000 inhabitants;Females;24 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;average stay by discharge;Both sexes;4.94 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;average stay by discharge;Males;4.61 Other sequelae, superficial injuries, contusions, crushing injuries and effects of foreign bodies Rest (905-939) *;average stay by discharge;Females;5.36 BURNS 940-949 XVII.6;patients discharged per 100,000 inhabitants;Both sexes;7 BURNS 940-949 XVII.6;patients discharged per 100,000 inhabitants;Males;9 BURNS 940-949 XVII.6;patients discharged per 100,000 inhabitants;Females;6 BURNS 940-949 XVII.6;average stay by discharge;Both sexes;11.41 BURNS 940-949 XVII.6;average stay by discharge;Males;11.32 BURNS 940-949 XVII.6;average stay by discharge;Females;11.57 POISONING AND TOXIC EFFECTS 960-989 XVII.7;patients discharged per 100,000 inhabitants;Both sexes;25 POISONING AND TOXIC EFFECTS 960-989 XVII.7;patients discharged per 100,000 inhabitants;Males;24 POISONING AND TOXIC EFFECTS 960-989 XVII.7;patients discharged per 100,000 inhabitants;Females;26 POISONING AND TOXIC EFFECTS 960-989 XVII.7;average stay by discharge;Both sexes;5.86 POISONING AND TOXIC EFFECTS 960-989 XVII.7;average stay by discharge;Males;5.83 POISONING AND TOXIC EFFECTS 960-989 XVII.7;average stay by discharge;Females;5.89 Poisoning by drugs, medicaments and biological substances 960-979;patients discharged per 100,000 inhabitants;Both sexes;20 Poisoning by drugs, medicaments and biological substances 960-979;patients discharged per 100,000 inhabitants;Males;18 Poisoning by drugs, medicaments and biological substances 960-979;patients discharged per 100,000 inhabitants;Females;22 Poisoning by drugs, medicaments and biological substances 960-979;average stay by discharge;Both sexes;6.02 Poisoning by drugs, medicaments and biological substances 960-979;average stay by discharge;Males;6.11 Poisoning by drugs, medicaments and biological substances 960-979;average stay by discharge;Females;5.96 Toxic effects of substances chiefly nonmedicinal as to source 980-989;patients discharged per 100,000 inhabitants;Both sexes;5 Toxic effects of substances chiefly nonmedicinal as to source 980-989;patients discharged per 100,000 inhabitants;Males;6 Toxic effects of substances chiefly nonmedicinal as to source 980-989;patients discharged per 100,000 inhabitants;Females;4 Toxic effects of substances chiefly nonmedicinal as to source 980-989;average stay by discharge;Both sexes;5.23 Toxic effects of substances chiefly nonmedicinal as to source 980-989;average stay by discharge;Males;4.99 Toxic effects of substances chiefly nonmedicinal as to source 980-989;average stay by discharge;Females;5.57 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;patients discharged per 100,000 inhabitants;Both sexes;13 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;patients discharged per 100,000 inhabitants;Males;13 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;patients discharged per 100,000 inhabitants;Females;13 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;average stay by discharge;Both sexes;5.59 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;average stay by discharge;Males;5.58 OTHER AND UNSPECIFIED EFFECTS OF EXTERNAL CAUSES 990-995 XVII.8;average stay by discharge;Females;5.60 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;patients discharged per 100,000 inhabitants;Both sexes;215 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;patients discharged per 100,000 inhabitants;Males;234 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;patients discharged per 100,000 inhabitants;Females;196 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;average stay by discharge;Both sexes;9.57 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;average stay by discharge;Males;9.42 COMPLICATIONS OF SURGICAL AND MEDICAL CARE, NOT CLASSIFIED ELSEWHERE 996-999 XVII.9;average stay by discharge;Females;9.74 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;patients discharged per 100,000 inhabitants;Both sexes;236 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;patients discharged per 100,000 inhabitants;Males;236 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;patients discharged per 100,000 inhabitants;Females;237 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;average stay by discharge;Both sexes;6.43 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;average stay by discharge;Males;6.58 V CODES FOR SPECIAL HOSPITALISATIONS (INCLUDING LIVE NEWBORNS IN HOSPITALS) V01-V82 (MAIN DIAGNOSIS) *;average stay by discharge;Females;6.29 DISCHARGES WITHOUT DIAGNOSIS;patients discharged per 100,000 inhabitants;Both sexes;42 DISCHARGES WITHOUT DIAGNOSIS;patients discharged per 100,000 inhabitants;Males;42 DISCHARGES WITHOUT DIAGNOSIS;patients discharged per 100,000 inhabitants;Females;41 DISCHARGES WITHOUT DIAGNOSIS;average stay by discharge;Both sexes;7.99 DISCHARGES WITHOUT DIAGNOSIS;average stay by discharge;Males;8.60 DISCHARGES WITHOUT DIAGNOSIS;average stay by discharge;Females;7.38